Search results for "embolism"

showing 10 items of 457 documents

Chronic thromboembolic disease following pulmonary embolism: more work ahead

2020

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryCardiologyMEDLINEmedicine.diseasePulmonary embolismWork (electrical)ThromboembolismAcute DiseasemedicineHumansThromboembolic diseasePulmonary EmbolismIntensive care medicinebusinessEuropean Respiratory Journal
researchProduct

Isolated Pulmonary Embolism Is Associated With a High Risk of Arterial Thrombotic Disease

2020

Background Isolated PE is associated with a higher burden of atherosclerotic disease than other manifestations of VTE. Research Question We hypothesized that the presence of isolated PE may signal a chronically elevated risk of arterial thrombotic disease. Study Design and Methods Data from the VTEval Study, a prospective cohort study enrolling individuals with clinical suspicion and imaging-based diagnosis or exclusion of VTE, were analyzed. Patients with PE received whole-leg ultrasonography to assess presence of DVT. Regularized logistic regression identified features that discriminate between isolated PE and other VTE phenotypes at clinical presentation. Survival analyses were performed…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryHazard ratioAtrial fibrillationCritical Care and Intensive Care Medicinemedicine.diseaseRate ratioThrombosisPulmonary embolismCoronary artery diseaseInternal medicinemedicineCardiologycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicineProspective cohort studybusinessChest
researchProduct

Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension

2017

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryHypertension PulmonaryAngiographyMiddle AgedPulmonary ArteryVascular RemodelingCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicine030228 respiratory system030220 oncology & carcinogenesisInternal medicineChronic DiseaseMicroscopy Electron ScanningCardiologymedicineHumansFemaleChronic thromboembolic pulmonary hypertensionPulmonary EmbolismbusinessLung TransplantationAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism

2021

BACKGROUND Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE). RESEARCH QUESTION What are the kinetics and determinants of disease-specific and generic health-related QoL 3 and 12 months following an acute PE? STUDY DESIGN AND METHODS The Follow-up after Acute Pulmonary Embolism (FOCUS) study prospectively followed up consecutive adult patients with objectively diagnosed PE. Patients were considered for study who completed the Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire at predefined visits 3 and 12 months following PE. The course of disease-specific QoL as assessed using the PEmb-QoL and the impact …

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryVisual analogue scalePatient-centered outcomesCritical Care and Intensive Care Medicinemedicine.diseasehumanitiesPulmonary embolismClinical trialQuality of lifeInterquartile rangeInternal medicineMedicineCardiology and Cardiovascular MedicinebusinessCohort studyCardiopulmonary diseaseChest
researchProduct

Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

2006

Cardiopulmonary function in patients with chronic thromboembolic pulmonary hypertension can almost be normalized by pulmonary endarterectomy. The procedure involves the removal of organized and incorporated fibrous obstructive tissue from the pulmonary arteries during circulatory arrest under deep hypothermia. Mortality rates reported for patients who have undergone pulmonary endarterectomy range from 4 to 24%. The operation is not an embolectomy but a true endarterectomy. After proximal intrapericardial pulmonary artery incision, the correct endarterectomy plane is established and circumferentially followed down to the lobar, segmental, and sometimes subsegmental pulmonary artery branches …

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentHypertension PulmonaryEmbolectomyArteriotomyEndarterectomyPulmonary ArteryPostoperative ComplicationsInternal medicinemedicine.arterymedicineHumansPulmonary wedge pressureEndarterectomyPostoperative CareLungbusiness.industryPatient Selectionmedicine.diseasePulmonary hypertensionSurgerymedicine.anatomical_structureTreatment OutcomePulmonary arteryChronic DiseaseCardiologyVascular resistancebusinessPulmonary EmbolismVascular Surgical ProceduresProceedings of the American Thoracic Society
researchProduct

Optimal management of hormonal contraceptives after an episode of venous thromboembolism

2019

Optimal management of hormonal contraception in patients with venous thromboembolism (VE) requires an individualized approach considering its potential benefits and complications during and after anticoagulant treatment. Potential benefits include prevention of pregnancy and mitigation of menstrual bleeding that is often worsened after start of anticoagulation therapy. Current evidence suggests that patients may opt for a continuation of (all forms of) hormonal contraception during anticoagulant treatment, provided that they are adequately informed by the treating physicians. Combined oral contraceptives should be stopped before anticoagulant therapy may he discontinued, preferably after th…

Quality of lifemedicine.medical_specialtymedia_common.quotation_subjectHormonal contraception030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeHumansMedicineIntensive care medicineMenstrual cyclemedia_commonPregnancybusiness.industryMenstrual bleedingAnticoagulantsHematologymedicine.diseaseOptimal managementContraceptives Oral CombinedMenstrual bleedingHormonal contraception030220 oncology & carcinogenesisFemalebusinessVenous thromboembolismHormoneVenous thromboembolism
researchProduct

Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial

2022

Abstract Aims The role of diuretics in patients with intermediate-risk pulmonary embolism (PE) is controversial. In this multicentre, double-blind trial, we randomly assigned normotensive patients with intermediate-risk PE to receive either a single 80 mg bolus of furosemide or a placebo. Methods and results Eligible patients had at least a simplified PE Severity Index (sPESI) ≥1 with right ventricular dysfunction. The primary efficacy endpoint assessed 24 h after randomization included (i) absence of oligo-anuria and (ii) normalization of all sPESI items. Safety outcomes were worsening renal function and major adverse outcomes at 48 hours defined by death, cardiac arrest, mechanical ventil…

Randomizationmedicine.medical_treatmentVentricular Dysfunction Right[SDV]Life Sciences [q-bio]Critical Care and Intensive Care MedicinePlacebolaw.inventionRandomized controlled trialDouble-Blind MethodlawFurosemidemedicineHumansDiureticsbusiness.industryFurosemideGeneral Medicinemedicine.diseasePulmonary embolismBlood pressureTreatment OutcomeAnesthesiaAcute DiseaseDiureticBolus (digestion)Cardiology and Cardiovascular MedicinebusinessPulmonary Embolismmedicine.drug
researchProduct

Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation

2013

Background Scores for cardio-embolic and bleeding risk in patients with atrial fibrillation are described in the literature. However, it is not clear how they co-classify elderly patients with multimorbidity, nor whether and how they affect the physician's decision on thromboprophylaxis. Methods Four scores for cardio-embolic and bleeding risks were retrospectively calculated for ≥ 65 year old patients with atrial fibrillation enrolled in the REPOSI registry. The co-classification of patients according to risk categories based on different score combinations was described and the relationship between risk categories tested. The association between the antithrombotic therapy received and t…

RegistrieMaleEmbolismAtrial fibrillation; Bleeding risk; Cardioembolic risk; Elderly; Prediction guides; Thromboprophylaxis; Aged; Aged; 80 and over; Anticoagulants; Atrial Fibrillation; Embolism; Female; Hemorrhage; Humans; Logistic Models; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Warfarin; Registries; Risk Assessment; Internal MedicineRetrospective Studiearitmiableeding risk scoreAtrial Fibrillation80 and overatrial fibrillationRegistriesStrokeAged 80 and overAspirineducation.field_of_studyElderly Atrial fibrillation Prediction guides Bleeding risk Cardioembolic risk ThromboprophylaxisPrediction guidesAtrial fibrillationCardiovascular diseaseStrokecardio-embolic scorePlatelet aggregation inhibitorcardio-embolic scores; bleeding risk scores; elderly; Atrial FibrillationFemaleRisk assessmentmedicine.drugHumanmedicine.medical_specialtyLogistic Modelcardio-embolic scoresPopulationHemorrhageRisk AssessmentelderlyCARDIOEMBOLIC RISKNOBLEEDING RISKInternal medicinemedicineElderly; Atrial fibrillation; Prediction guides; Bleeding risk; Cardioembolic riskbleeding risk scoresPrediction guideInternal MedicineHumanseducationThromboprophylaxisAgedRetrospective StudiesELDERLYbusiness.industryPlatelet Aggregation InhibitorSettore MED/09 - MEDICINA INTERNAWarfarinAnticoagulantAnticoagulantsRetrospective cohort studyAtrial fibrillation; Bleeding risk; Cardioembolic risk; Elderly; Prediction guides; Thromboprophylaxis; Aged; Aged 80 and over; Anticoagulants; Atrial Fibrillation; Embolism; Female; Hemorrhage; Humans; Logistic Models; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Warfarin; Registries; Risk Assessment; Internal Medicinemedicine.diseaseSurgeryLogistic ModelsThromboprophylaxiWarfarinbusinessPlatelet Aggregation Inhibitors
researchProduct

When sepsis affects the heart: A case report and literature review

2015

A 59-year-old nursing home patient with Down syndrome was brought to the internal medicine department of our hospital due to fever, cough without expectorate, and dyspnea. A thoracic computed tomography revealed the presence of bilateral basal parenchymal opacities. Her condition deteriorated after admission and troponin reached a peak serum concentration of 16.9 ng/mL. The patient was in cardiogenic shock. In addition to fluid resuscitation, vaso-active amine infusion was administered to achieve hemodynamic stabilization. The differential diagnosis investigated possible pulmonary embolism, myocardial infarction, and myocarditis. Furthermore, a second transthoracic echocardiogram suggested …

Resuscitationmedicine.medical_specialtyMyocarditisbusiness.industryCardiogenic shockCase ReportGeneral Medicinemedicine.diseasePulmonary embolismSurgerySepsisInternal medicineShock (circulatory)medicineCardiologyMyocardial infarctionmedicine.symptomTransthoracic echocardiogrambusiness
researchProduct

The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes

2015

Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism in the ICU setting. We therefore evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill patients. We also tried to determine whether currently adopted prophylactic measures need to be revised and improved in the ICU setting. Materials and methods. MEDLINE and EMBASE databases were searched up…

RiskCritical IllnessIntensive Care UnitCritically ill patients; Deep vein thrombosis; Meta-analysis; Outcomes; Cohort Studies; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Respiration Artificial; Risk; Thrombophilia; Treatment Outcome; Venous Thrombosis; Critical Illness; Hematology; Immunology and AllergyReviewDeep Vein Thrombosis Critically Ill Patients outcomes metanalysisCohort StudiesDeep vein thrombosiImmunology and AllergyHumansThrombophiliaMeta-analysiVenous ThrombosiHospital MortalityOutcomeRandomized Controlled Trials as TopicVenous ThrombosisHematologyLength of StayRespiration ArtificialIntensive Care UnitsTreatment OutcomeResearch DesignCritical IllneCritically ill patientCohort StudiePulmonary EmbolismHuman
researchProduct